Journal of Neuro-Oncology

, Volume 95, Issue 2, pp 293–298 | Cite as

Anaplastic oligoastrocytoma in Turcot syndrome

  • Joachim Baehring
  • Pei Hui
  • Joseph Piepmeier
  • Serguei I. Bannykh
Case Report

Abstract

Turcot syndrome (TS), a rare variant of hereditary non-polyposis colorectal cancer (HNPCC), is characterized by familial clustering of cancer of the large bowel, extracolonic body sites and brain. It is caused by germline mutations in genes encoding for components of the DNA mismatch repair system. We report a 72 year old woman with anaplastic oligoastrocytoma in the setting of TS. Careful analysis of tumor DNA is required to exclude the chance occurrence of a brain tumor in HNPCC kindreds and increase our understanding of the pathogenesis of the disease. Our case adds to the handful of cases published with detailed molecular data previously.

Keywords

HNPCC Turcot Brain Microsatellite instability Oligoastrocytoma Glioma PTEN 

References

  1. 1.
    Turcot J, Despres JP, St. Pierre F (1959) Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465–468. doi:10.1007/BF02616938 CrossRefPubMedGoogle Scholar
  2. 2.
    Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535–1549CrossRefPubMedGoogle Scholar
  3. 3.
    Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038. doi:10.1016/0092-8674(93)90546-3 CrossRefPubMedGoogle Scholar
  4. 4.
    Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK et al (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258–261. doi:10.1038/368258a0 CrossRefPubMedGoogle Scholar
  5. 5.
    Wijnen J, De Leeuw W, Vasen H, van der Klift H, Moller P, Stormorken A et al (1999) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142–144. doi:10.1038/13773 CrossRefPubMedGoogle Scholar
  6. 6.
    Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM et al (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75–80. doi:10.1038/371075a0 CrossRefPubMedGoogle Scholar
  7. 7.
    Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561. doi:10.1038/363558a0 CrossRefPubMedGoogle Scholar
  9. 9.
    Vasen HF, Sanders EA, Taal BG, Nagengast FM, Griffioen G, Menko FH et al (1996) The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer 65:422–425. doi:10.1002/(SICI)1097-0215(19960208)65:4<422::AID-IJC4>3.0.CO;2-Z CrossRefPubMedGoogle Scholar
  10. 10.
    Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430–433. doi:10.1002/ijc.2910640613 CrossRefPubMedGoogle Scholar
  11. 11.
    Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR (2000) Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2:20–28CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MR, Morrison P et al (1994) Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 24:516–526. doi:10.1006/geno.1994.1661 CrossRefPubMedGoogle Scholar
  13. 13.
    Guanti G, Resta N, Simone C, Cariola F, Demma I, Fiorente P et al (2000) Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet 9:283–287. doi:10.1093/hmg/9.2.283 CrossRefPubMedGoogle Scholar
  14. 14.
    InSight Mutation Database (2008) International Society for Gastrointestinal Hereditary TumorsGoogle Scholar
  15. 15.
    Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338. doi:10.1126/science.7761852 CrossRefPubMedGoogle Scholar
  16. 16.
    Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC et al (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967–969. doi:10.1126/science.275.5302.967 CrossRefPubMedGoogle Scholar
  17. 17.
    Malkhosyan S, Rampino N, Yamamoto H, Perucho M (1996) Frameshift mutator mutations. Nature 382:499–500. doi:10.1038/382499a0 CrossRefPubMedGoogle Scholar
  18. 18.
    Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM et al (1996) Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 14:255–257. doi:10.1038/ng1196-255 CrossRefPubMedGoogle Scholar
  19. 19.
    Chan TL, Yuen ST, Chung LP, Ho JW, Kwan K, Fan YW et al (1999) Germline hMSH2 and differential somatic mutations in patients with Turcot’s syndrome. Genes Chromosomes Cancer 25:75–81. doi:10.1002/(SICI)1098-2264(199906)25:2<75::AID-GCC1>3.0.CO;2-1 CrossRefPubMedGoogle Scholar
  20. 20.
    Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M et al (1997) Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene 15:2877–2881. doi:10.1038/sj.onc.1201668 CrossRefPubMedGoogle Scholar
  21. 21.
    Buerstedde JM, Alday P, Torhorst J, Weber W, Muller H, Scott R (1995) Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet 32:909–912. doi:10.1136/jmg.32.11.909 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Merlo A, Rochlitz C, Scott R (1996) Survival of patients with Turcot’s syndrome and glioblastoma. N Engl J Med 334:736–737. doi:10.1056/NEJM199603143341118 CrossRefPubMedGoogle Scholar
  23. 23.
    Gonda K, Nomizu T, Fukayama N, Sugano K, Takenosita S (2002) A novel germline mutation of hMLH1 in a patient with hereditary non-polyposis colorectal cancer. Jpn J Clin Oncol 32:215–218. doi:10.1093/jjco/hyf048 CrossRefPubMedGoogle Scholar
  24. 24.
    Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM et al (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847. doi:10.1056/NEJM199503303321302 CrossRefPubMedGoogle Scholar
  25. 25.
    Grips E, Wentzensen N, Sutter C, Sedlaczek O, Gebert J, Weigel R et al (2002) Glioblastoma multiforme as a manifestation of Turcot syndrome. Nervenarzt 73:177–182. doi:10.1007/s00115-001-1233-8 CrossRefPubMedGoogle Scholar
  26. 26.
    Taylor MD, Perry J, Zlatescu MC, Stemmer-Rachamimov AO, Ang LC, Ino Y et al (1999) The hPMS2 exon 5 mutation and malignant glioma. Case report. J Neurosurg 90:946–950CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Joachim Baehring
    • 1
    • 2
  • Pei Hui
    • 3
  • Joseph Piepmeier
    • 2
  • Serguei I. Bannykh
    • 4
  1. 1.Department of NeurologyYale University School of MedicineNew HavenCTUSA
  2. 2.Department of NeurosurgeryYale University School of MedicineNew HavenUSA
  3. 3.Department of PathologyYale University School of MedicineNew HavenUSA
  4. 4.Department of PathologyCedars Sinai Medical CenterLos AngelesUSA

Personalised recommendations